FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule

 

Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.

Oncologic Drugs Advisory Committee

September 6, 2006

Ronald Bukowski, M.D.

• 18 U.S.C. 208 waiver (pdf)
• Acknowledgement and Consent (pdf)

Stephen George, Ph.D.

• 18 U.S.C. 208 waiver (pdf)
• Acknowledgement and Consent (pdf)

David Harrington, Ph.D.

• 18 U.S.C. 208 waiver (pdf)
• Acknowledgement and Consent (pdf)

Pamela J. Haylock, R.N., M.A., Ph.D. (c)

• Acknowledgement and Consent (pdf)

William Hiatt, M.D.

• 18 U.S.C. 208 waiver (pdf)
• Acknowledgement and Consent (pdf)

Maha Hussain, M.D.

• 18 U.S.C. 208 waiver (pdf)
• Acknowledgement and Consent (pdf)

Michael Perry, M.D.

Acknowledgement and Consent (pdf )

Karl Schwartz

Acknowledgement and Consent (pdf )


Page updated: August 30, 2006